| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/11/1993 | CA1317545C Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 05/05/1993 | EP0540143A2 Compounds and methods for inhibition of HIV and related viruses |
| 05/05/1993 | EP0539751A1 Biodegradable polymer composition |
| 05/05/1993 | EP0486526A4 Tumour necrosis factor binding ligands |
| 05/05/1993 | CA2081808A1 Combination of calcium antagonists with cholinesterase inhibitors |
| 05/04/1993 | CA1317228C Pharmaceutical preparation containing b-blocker and a potassium channel activator |
| 05/04/1993 | CA1317224C Method and composition for the treatment and prevention of viral infections |
| 04/29/1993 | WO1993007903A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 04/29/1993 | WO1993007902A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 04/29/1993 | WO1993007866A2 Compositions and methods for therapy and prevention of cancer, aids, and anemia |
| 04/29/1993 | CA2120927A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 04/28/1993 | CN1071333A Calcium receptor active molecules |
| 04/27/1993 | US5206345 Binding specifically to epitope of cell surface; monoclonal antibodies and antigen-binding fragments |
| 04/27/1993 | US5206264 Reduces damage caused by hypoxic or ischemic events |
| 04/27/1993 | US5206218 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 04/27/1993 | US5206023 Method and compositions for the treatment and repair of defects or lesions in cartilage |
| 04/27/1993 | US5206008 Using androstene(diol or triol) |
| 04/27/1993 | CA1316823C Facilitation of certain drugs for capsulation |
| 04/21/1993 | EP0537437A2 Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines |
| 04/21/1993 | EP0537191A1 Treatment of organ transplantation rejection |
| 04/20/1993 | US5204329 4-Quinoline carboxylic acid derivatives |
| 04/17/1993 | WO1993007892A1 Composition and treatment with biologically active peptides and antibiotic |
| 04/17/1993 | CA2120337A1 Composition and treatment with biologically active peptides and antibiotic |
| 04/15/1993 | WO1993007265A1 Treatment of cystic fibrosis |
| 04/15/1993 | WO1993006852A2 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 04/15/1993 | WO1993006839A1 Method for enhancing gut absorption |
| 04/15/1993 | WO1993006812A2 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 04/15/1993 | WO1992020328A3 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 04/15/1993 | DE4133694A1 Verwendung einer emulsion, zur herstellung eines arzneimittels zur iv-verabreichung zur behandlung von hauterkrankungen Use of an emulsion, for the manufacture of a medicament for intravenous administration for the treatment of skin diseases |
| 04/14/1993 | EP0536299A1 Surface complexed lymphotoxin |
| 04/14/1993 | EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/14/1993 | EP0536119A1 Immunoregulatory agents |
| 04/13/1993 | US5202029 High performance liquid chromatography |
| 04/08/1993 | WO1993006834A1 Enteral preparation for cancer therapy |
| 04/07/1993 | EP0535390A1 The use of L-2-oxothiazolidine-4-carboxylate for the preparation of a medicament for treating latent HIV infection |
| 04/07/1993 | EP0535021A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 04/06/1993 | CA1315690C Synergistic combination of decarboxylase inhibitors and l-dopa pellets |
| 04/06/1993 | CA1315678C Alpha-tocopherol based vesicles |
| 04/01/1993 | WO1993005800A1 Method and compositions for the treatment of cerebral palsy |
| 04/01/1993 | WO1993005795A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds |
| 04/01/1993 | WO1993005794A1 Preservative for pharmaceutical products |
| 04/01/1993 | WO1993005786A1 Novel gabaa receptor with steroid binding sites |
| 04/01/1993 | WO1993005752A1 Cosmetic and dermatological preparations |
| 04/01/1993 | DE4131940A1 Kosmetische und dermatologische zubereitungen Cosmetic and dermatological preparations |
| 04/01/1993 | CA2119444A1 Preservative for pharmaceutical products |
| 04/01/1993 | CA2118938A1 Novel gabaa receptor with steroid binding sites |
| 03/31/1993 | EP0533832A1 Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| 03/31/1993 | EP0533770A1 Novel treatment |
| 03/31/1993 | EP0295248B1 Liposome preparation and antibiotic |
| 03/31/1993 | CA2077966A1 Method of and a composition for treatment of latent virus infection |
| 03/30/1993 | US5198220 Drug delivery, polylactide/glycolide |
| 03/24/1993 | EP0533281A1 The use of ranitidine bismuth citrate and one or more heliocobacte pylon-inhibiting antibiotics with manufacture of a medicament for treating gastrointestinal disorders |
| 03/24/1993 | EP0533280A1 Novel medical use for tachykinin antagonists |
| 03/23/1993 | US5196205 Method for treatment of gastro intestinal disorders |
| 03/21/1993 | CA2078579A1 Medicaments for treating gastrointestinal disorders |
| 03/18/1993 | WO1993004688A1 Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
| 03/17/1993 | CN1069882A Compounds and methods for inhibition of HIV and related viruses |
| 03/16/1993 | US5194594 Conjugation With Heterobifunctional Reagent, Radionucleotide Label |
| 03/16/1993 | US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 03/16/1993 | US5194259 Plant extracts |
| 03/16/1993 | CA1314484C Synergistic combination of azelastine and theophylline or azelastine and .beta.-mimetics |
| 03/16/1993 | CA1314481C Liposomal preparation and antibiotic |
| 03/10/1993 | EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof |
| 03/10/1993 | EP0439570B1 A novel use of beta-receptor blocking agents for treatment of menieres' disease |
| 03/10/1993 | CN1069741A Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 03/09/1993 | US5192780 Methods using antiallergics and antihistamines |
| 03/09/1993 | US5192753 Anti-rheumatoid arthritic drugs in the treatment of dementia |
| 03/09/1993 | US5192527 Method of reversing local anesthesia and reagent system therefor |
| 03/09/1993 | CA1314223C Composition for treating gastrointestinal disorders |
| 03/04/1993 | WO1993004373A1 Calcium receptor active molecules |
| 03/04/1993 | WO1993003724A1 Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride |
| 03/04/1993 | WO1993003723A1 Leukotriene receptor antagonist-antihistamine complex |
| 03/04/1993 | WO1993003713A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 03/04/1993 | WO1992020796A3 D-type cyclin and uses related thereto |
| 03/04/1993 | WO1992018089A3 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells |
| 03/04/1993 | CA2114945A1 Leukotriene receptor antagonist-antihistamine complex |
| 03/03/1993 | EP0529484A1 Antitussive and expectorant composition |
| 03/03/1993 | EP0446225B1 Medicament for treatment of pathological vascular permeability and plasma loss to tissue |
| 03/03/1993 | EP0419501B1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| 03/02/1993 | US5191067 For treatment of fibroblast growth factor mediated pathophysiological conditions |
| 03/02/1993 | US5190962 Treating hypertension |
| 03/02/1993 | US5190763 Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
| 02/28/1993 | CA2076114A1 Antitussive and expectorant composition |
| 02/25/1993 | DE4127469A1 Compsn. contg. chemotherapeutic agent and lithium salt - for treatment of bacterial or viral infection e.g. HSV and HIV, malaria, leishmaniasis, trypanosoma infection and Candida albicans |
| 02/24/1993 | EP0528527A2 Conjugates |
| 02/24/1993 | EP0528515A2 HMG-CoA reductase inhibitors in the prevention of restenosis following coronary angioplasty |
| 02/24/1993 | EP0528468A1 Use of triclosan for the manufacture of a medicament for inhibiting cyclooxygenase |
| 02/24/1993 | EP0527979A1 Pharmaceutical for treating viral diseases |
| 02/24/1993 | EP0527917A1 Use of adenosine and adenosine derivatives for anesthesia |
| 02/18/1993 | WO1993003022A1 Compounds and methods for inhibition of hiv and related viruses |
| 02/18/1993 | WO1993002708A1 Novel reagent for tumour imaging and therapy |
| 02/18/1993 | WO1993002707A1 New anti-diarrheic agents |
| 02/18/1993 | WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 02/18/1993 | WO1992022299A3 Use of antiarrhythmic agents to lower cholesterol |
| 02/17/1993 | EP0527624A2 Use of a selective inhibitor of neutral endopeptidase and an angiotensin converting enzyme inhibitor in the preparation of a pharmaceutical for treating congestive heart failure |
| 02/17/1993 | EP0527540A1 Medicament for the treatment of withdrawal symptoms |
| 02/13/1993 | CA2075671A1 Treatment of congestive heart failure |
| 02/10/1993 | EP0527056A1 Novel reagent for tumour imaging and therapy |
| 02/10/1993 | EP0526756A1 Composition for revitalizing scar tissue |
| 02/10/1993 | EP0526700A2 Drug-containing protein-bonded liposome |